ICD promotes dendritic cell (DC) recruitment and activation by exposing calreticulin (CRT) on the tumor cell surface and releasing intracellular damage-associated molecular patterns (DAMPs), thereby enhancing tumor antigen uptake by DCs [27,28]. The gene discussed is CALR; the disease is neoplasm.